Cytek Investor Conference Presentation Deck
Cytek Technology Enables Applications; >1,450 FSP Peer Reviewed Publications
Total Peer Reviewed
Scientific Publication by Application
13.30%
23.30%
O
20.40%
25.80%
17.20%
CYTEK
TRANSCEND THE CONVENTIONAL
■ Oncology
■ Vaccines/Viral infection
■
Immunology/Therapies
■ Inflammation/Autoimmunity
1
Drug Development/other
Cella
Cancer
Research
AAGR
JCI insIGHT
www
Temer specie stress drives
unique pattern of resistance to immag
The Journal of
Immunology
Why Customers Choose Cytek
nature
INSIDE GREEN
FLUORESCENT
PROTEIN
Science
Advances
MAAAS
Deeper assessment of patient immune status - before and
after treatment
Maximize the value of a lab sample with more information
in less time with fewer errors
.LO
Fully Standardized across experiments and laboratory sites.
More powerful system at a lower cost with minimal
learning curve
7View entire presentation